Sezary disease is a type of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. The involvement of the inguinal region and lower limb nodes is clinically significant, as it indicates disease progression and potential complications. Accurate coding with ICD-10 Code C84.15 is essential for proper diagnosis, documentation, medical billing, and public health reporting.
ICD-10 Code C84.15 specifically denotes Sezary disease affecting the lymph nodes in the inguinal region and lower limb. This code is used when documenting cases of Sezary disease that present with lymphadenopathy in these areas, facilitating accurate clinical documentation and billing for healthcare services related to this condition.
Sezary disease is a leukemic form of cutaneous T-cell lymphoma, primarily affecting the skin and lymphatic system. It is characterized by the proliferation of malignant T-cells, leading to systemic symptoms and lymphadenopathy, particularly in the inguinal region and lower limbs. Prompt medical attention is crucial due to the potential for disease progression and complications.
ICD-10 Code C84.15 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Sezary disease. This code aids in capturing the severity and specific manifestations of the disease, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.15 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Sezary disease. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Sezary disease requires urgent medical intervention due to its aggressive nature. Treatment may involve systemic therapies and supportive care to manage symptoms and prevent complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.15 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96401 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C84.15 for Sezary disease, nodes of inguinal region and lower limb
What are the common symptoms of Sezary disease?
Common symptoms include extensive skin redness (erythroderma), severe itching, swollen lymph nodes, and fatigue. Patients may also experience weight loss and secondary infections due to skin barrier disruption.
How is Sezary disease diagnosed?
Diagnosis typically involves a combination of clinical examination, blood tests to identify atypical T-cells, and skin biopsies to confirm the presence of cutaneous T-cell lymphoma.
What treatments are available for Sezary disease?
Treatment options include systemic therapies such as methotrexate or gemcitabine, topical corticosteroids for skin symptoms, and supportive care to manage complications and improve quality of life.
Is Sezary disease contagious?
No, Sezary disease is not contagious. It is a type of cancer that arises from the skin's T-cells and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes